News
-
-
-
PRESS RELEASE
Protagonist Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Protagonist Therapeutics reports $165.0 million milestone achieved in Q4 2024 and key milestones for 2025 including icotrokinra and rusfertide trial results. Financial results for Q4 2024 revealed -
PRESS RELEASE
EQS-Adhoc: RIXX Invest AG: RIXX Invest AG Resolves Strategic Realignment - Transformation into Innovative Value-Add Investor
RIXX Invest AG announces strategic realignment into innovative value-add investor, focusing on oil and gas, crypto mining, real estate, and venture capital segments -
-
-
-
PRESS RELEASE
Multitude AG Launches All-Employees Shareholder Programme to Strengthen Employee Ownership
Multitude AG launches its All-Employees Shareholder Programme to strengthen employee ownership and align interests between employees and shareholders. The programme includes granting eligible employees 50 free Multitude shares annually -
-
PRESS RELEASE
Eleving Group waives the right to prepay the 2023/2028 Eurobonds earlier than October 31, 2026
Eleving Group to waive early prepayment right for 2023/2028 Eurobonds, announces public bond offering. Terms revised, no prepayment before Oct 31, 2026. Offered with 13% p.a. coupon rate, maturing Oct 31, 2028